Predictor-driven Dissection of the Post-COVID Syndrome (PCS) Score - A Population-Based Study
Ballhausen,S.,Russ,A.,Lieb,W.,Horn,A.,Krist,L.,Fricke,J.,Scheibenbogen,C.,Rabe,K. F.,Maetzler,W.,Maetzler,C.,Laudien,M.,Frank,D.,Heyckendorf,J.,Miljukov,O.,Haeusler,K. G.,El Mokthari,N. E.,Witzenrath,M.,Vehreschild,J. J.,Appel,K. S.,Chaplinskaya-Sobol,I.,Tamminga,T.,Nürnberger,C.,Schmidbauer,L.,Morbach,C.,Störk,S.,Reese,J. P.,Keil,T.,Heuschmann,P.,Schreiber,S.,Krawczak,M.,Bahmer,T.
DOI: https://doi.org/10.1183/13993003.congress-2024.pa5109
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Background: The term 'Post-COVID Syndrome' (PCS) encompasses the multifaceted sequelae of COVID-19. A previously developed PCS scoring system used data from 667 participants in a prospective, multicentre, population-based study (COVIDOM/ NAPKON-POP), grading PCS severity based on 12 symptom complexes. Acute COVID-19 severity and individual resilience were identified as predictors, indicating two aetiologically and clinically distinct PCS sub-phenotypes. Aim: We established two novel scores from non-overlapping subsets of PCS symptom complexes in order to enhance the specificity of the scoring system. Methods: Symptom complexes were sub-selected by CART analyses and the new scores were applied in a expanded dataset (n=2,771). The newly defined resilience-specific PCS-R score comprised: persistent neurological symptoms, fatigue, and sleep disturbances. The acute severity-specific PCS-S score included: signs of acute infection, chemosensory deficits, exercise intolerance, and joint or muscle pain. Results: Each novel PCS score was specific for COVID-19 severity and resilience, as intended, and subsequently validated in two sub-cohorts. In addition to the known predictors, the PCS-R score was significantly influenced by the patients' level of education and pre-existing neurological or psychiatric diseases (all p<0.05). Both novel scores exhibited a significant inverse correlation with quality of life (EQ-5D-5L index; PCS-R: r=-0.62; PCS-S: r=-0.50; both p<0.001). Conclusion: The two novel PCS scores allow for a more nuanced approach to assessing PCS severity and heterogeneity, highlighting the clinical need for different therapeutic and interventional strategies in these distinct PCS phenotypes.
respiratory system